SCHEMBL10212660

SCHEMBL10212660

Cc1[nH]c(C(=O)N[C@@H]2CCN(c3nc(-c4cnc(NCCN5CCNC5=O)cn4)c(C(=O)O)s3)C[C@@H]2C)c(Cl)c1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10211746 0.93 — —
SCHEMBL10211740 0.92 — —
SCHEMBL10170311 0.91 — —
SCHEMBL10214984 0.91 — —
SCHEMBL10211800 0.89 — —
SCHEMBL10211804 0.89 — —
SCHEMBL10211742 0.89 ABCC2 (0.58) —
SCHEMBL10212748 0.88 — —
SCHEMBL10214311 0.86 ABCC2 (0.47) —
SCHEMBL3112531 0.86 ABCC2 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028979-A1 2-(PIPERIDIN-1-YL)-4-HETEROCYCLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2012-02-02 — — US disclosed
US-8071605-B2 Piperidine compounds for use in the treatment of bacterial infections ASTRAZENECA AB (SE) 2011-12-06 — — US disclosed
US-20100173909-A1 PIPERIDINE COMPOUNDS AND USES THEREOF - 596 ASTRAZENECA AB (SE) 2010-07-08 — — US disclosed
Send feedback